Choose your location
Select your country or region to view content specific to your country.
Choose your country
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in each country.
Introducing Seegene's achievements and vision in the U.S.
Oct 17, 2022
On October 14,
2022, Richard Creager, president of Seegene USA, visited the headquarters to
share recent major achievements and business plans and vision for 2023.
Creager described
the outstanding outcomes in 2022, recruiting leaders and talents in various
fields in the United States and building infrastructure such as R&D centers
and manufacturing facilities. He also carried out various tasks to solidify the
relationship with Seegene’s partner Bio-Rad and introduced an improved sales
and marketing processes to promote NovaplexTM Assays, a RUO
(research use only) product line, in the local market
And "For
the purpose of smooth manufacturing and sales in the United States, we’re
establishing a quality management system that meets FDA standards and a
management policy for transparent financial management. We’ll make it possible
for them to obtain FDA approval.
We'll aim to enter the top 5 in the US molecular diagnostics market in ten years based on innovative technology." He revealed his aspirations.